These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 2212804)
41. [Danazol and its effect on bone and lipid metabolism in patients with endometriosis]. Duque G; Bianchi M; Fernández C; Arteaga E Rev Chil Obstet Ginecol; 1995; 60(1):34-7. PubMed ID: 8525034 [TBL] [Abstract][Full Text] [Related]
42. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. Dodin S; Lemay A; Maheux R; Dumont M; Turcot-Lemay L Obstet Gynecol; 1991 Mar; 77(3):410-5. PubMed ID: 1825135 [TBL] [Abstract][Full Text] [Related]
44. Hormonal therapies for endometriosis: implications for bone metabolism. Dawood MY Acta Obstet Gynecol Scand Suppl; 1994; 159():22-34. PubMed ID: 8209669 [TBL] [Abstract][Full Text] [Related]
45. [Age-dependent decrease in plasma androgens, and role of androgens in bone mineral density and bone metabolism]. Adachi M; Takayanagi R Clin Calcium; 2006 Mar; 16(3):419-27. PubMed ID: 16508123 [TBL] [Abstract][Full Text] [Related]
46. [Effect of danazol on bone mineral content and bone metabolism in patients with endometriosis]. Ohta H; Nemoto K; Nozawa S; Tamura S; Iizuka R Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jul; 42(7):675-81. PubMed ID: 2212804 [TBL] [Abstract][Full Text] [Related]